# Oral Antibiotics for Anal Abscess

> **NCT03643198** · NA · UNKNOWN · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 210 (estimated)

## Conditions studied

- Anal Fistula
- Anal Abscess

## Interventions

- **DRUG:** ANTIBIOTIC (METRONIDAZOLE AND CIPROFLOXACIN)
- **OTHER:** CONTROL

## Key facts

- **NCT ID:** NCT03643198
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03643198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03643198, "Oral Antibiotics for Anal Abscess". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03643198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*